Email this article Solitary (extramedullary) plasmocytoma. Clinical recommendations
- Authors: Falaleeva N.A.1, Terekhova A.I.1, Ptushkin V.V.2, Osmanov E.A.3,4, Poddubnaya I.V.5, Nevol’skikh A.A.1, Ivanov S.A.1, Khailova Z.V.1, Gevorkian T.G.1
-
Affiliations:
- Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
- Botkin City Clinical Hospital
- Blokhin National Medical Research Center of Oncology
- Sechenov First Moscow State Medical University (Sechenov University)
- Russian Medical Academy of Continuous Professional Education
- Issue: Vol 22, No 1 (2020)
- Pages: 7-15
- Section: CLINICAL ONCOLOGY
- URL: https://journals.rcsi.science/1815-1434/article/view/34165
- DOI: https://doi.org/10.26442/18151434.2020.1.200048
- ID: 34165
Cite item
Full Text
Abstract
Solitary (extramedullary) plasmocytoma. Clinical recommendations
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Natal’ia A. Falaleeva
Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
Author for correspondence.
Email: or@hpmp.ru
д-р мед. наук, зав. отд-нием противоопухолевого лекарственного лечения; д-р мед. наук, зав. отд-нием противоопухолевого лекарственного лечения
Russian Federation, MoscowAlena Iu. Terekhova
Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
Email: or@hpmp.ru
канд. мед. наук, зав. отд-нием лучевого и лекарственного лечения гемобластозов
Russian Federation, MoscowVadim V. Ptushkin
Botkin City Clinical Hospital
Email: or@hpmp.ru
д-р мед. наук, проф., зам. глав. врача по гематологии; гл. внештат. специалист-гематолог Департамента здравоохранения г. Москвы, член Национального гематологического общества и Российского общества онкогематологов
Russian Federation, MoscowEvgenii A. Osmanov
Blokhin National Medical Research Center of Oncology; Sechenov First Moscow State Medical University (Sechenov University)
Email: or@hpmp.ru
д-р мед. наук, проф., зав. отд. гематологии и трансплантации костного мозга; проф. каф. онкологии; член правления Национального гематологического общества
Russian Federation, MoscowIrina V. Poddubnaya
Russian Medical Academy of Continuous Professional Education
Email: or@hpmp.ru
академик РАН, д-р мед. наук, проф., зав. каф. онкологии и паллиативной медицины, проректор по лечебной работе и международному сотрудничеству
Russian Federation, MoscowAleksei A. Nevol’skikh
Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
Email: or@hpmp.ru
д-р мед. наук, зам. дир. по лечебной работе
Russian Federation, MoscowSergei A. Ivanov
Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
Email: or@hpmp.ru
проф. РАН, д-р мед. наук, дир.
Russian Federation, MoscowZhanna V. Khailova
Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
Email: or@hpmp.ru
канд. мед. наук, зам. дир. по организационно-методической работе
Russian Federation, MoscowTigran G. Gevorkian
Tsyba Medical Radiological Scientific Center – branch of the National Medical Research Center for Radiology
Email: or@hpmp.ru
Russian Federation, Moscow
References
- Rajkumar SV, Dimopoulos MA, Palumbo A et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15 (12): e538–e548.
- Furukawa Y, Kikuchi J. Molecular pathogenesis of multiple myeloma. Int J Clin Oncol 2015; 20 (3): 413–22.
- Lewis EB. Leukemia, Multiple Myeloma, and Aplastic Anemia in American Radiologists. Science 1963; 142 (3598): 1492–4.
- Linet MS, Harlow SD, McLaughlin JK. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Res 1987; 47 (11): 2978–81.
- Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91 (1): 3–21.
- Swerdlow SH, Campo E, Harris NL et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: International Agency for Research in Cancer (IARC) 2017.
- Caers J et al. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol 2018; 11 (1): 10.
- Grammatico S, Scalzulli E, Petrucci MT. Solitary Plasmacytoma. Mediterr J Hematol Infect Dis 2017; 9 (91): 1–14.
- Guo SQ et al. Prognostic factors associated with solitary plasmacytoma. Onco Targets Ther 2013; 6: 1659–66.
- Вотякова О.М., Менделеева Л.П. Солитарная плазмоцитома. Российские клинические рекомендации по диагностике и лечению злокачественных лимфопролиферативных заболеваний. Под ред. И.В. Поддубной, В.Г. Савченко. М., 2018; с. 302–7.v[Votyakova O.M., Mendeleev L.P. Solitary plasmacytoma. Russian clinical guidelines for the diagnosis and treatment of malignant lymphoproliferative diseases. Ed. I.V.Poddubnaya, V.G.Savchenko. Moscow, 2018; p. 302–7 (in Russian).]
- Wilder RB et al. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer 2002; 94 (5): 1532–7.
- Thakar YS et al. Immunochemical studies in multiple myeloma. Indian J Cancer 1997; 34 (4): 151–8.
- Hill QA et al. Outcome prediction in plasmacytoma of bone: A risk model utilizing bone marrow flow cytometry and light-chain analysis. Blood 2014; 124 (8): 1296–9.
- Dingli D et al. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 2006; 108 (6): 1979–83.
- Менделеева Л.П., Вотякова О.М., Рехтина И.Г. Множественная миелома. Российские клинические рекомендации по диагностике и лечению злокачественных лимфопролиферативных заболеваний. Под ред. И.В. Поддубной, В.Г. Савченко. М., 2018; с. 213–41. [Mendeleev L.P., Votyakova O.M., Rekhtina I.G. Multiple myeloma Russian clinical guidelines for the diagnosis and treatment of malignant lymphoproliferative diseases. Ed. I.V.Poddubnaya, V.G.Savchenko. Moscow, 2018; p. 213–41 (in Russian).]
- Zamagni E et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007; 92 (1): 50–5.
- Mendenhall WM, Mendenhall CM, Mendenhall NP. Solitary plasmacytoma of bone and soft tissues. Am J Otolaryngol 2003; 24 (6): 395–9.
- Tsang RW et al. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2018; 101 (4): 794–808.
- Tsang RW et al. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 2001; 50 (1): 113–20.
- Paul KL. Rehabilitation and exercise considerations in hematologic malignancies. Am J Phys Med Rehabil 2011; 90 (5 Suppl. 1): S88–94.
- Oken MM et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5 (6): 649–55.
Supplementary files
